Bahl & Gaynor Inc Balchem Corp Transaction History

Bahl & Gaynor Inc

$17.9 Billion
Q2 2024

A detailed history of Bahl & Gaynor Inc transactions in Balchem Corp stock. As of the latest transaction made, Bahl & Gaynor Inc holds 46,338 shares of BCPC stock, worth $8.07 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

46,338

Previous 45,829 1.11%

Holding current value

$8.07 Million

Previous $7.1 Million 0.45%

% of portfolio

0.04%

Previous 0.04%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$138.5 - $156.63 $70,496 - $79,724	509 Added 1.11%	46,338 $7.13 Million
Q1 2024 May 10, 2024	SELL	$137.06 - $157.27 $31,386 - $36,014	-229 Reduced 0.5%	45,829 $7.1 Million
Q4 2023 Feb 02, 2024	BUY	$115.08 - $150.35 $131,536 - $171,850	1,143 Added 2.54%	46,058 $6.85 Million
Q3 2023 Nov 03, 2023	SELL	$123.38 - $142.72 $35,163 - $40,675	-285 Reduced 0.63%	44,915 $5.57 Million
Q2 2023 Aug 14, 2023	SELL	$122.28 - $136.64 $75,446 - $84,306	-617 Reduced 1.35%	45,200 $6.09 Million
Q1 2023 May 03, 2023	SELL	$117.39 - $142.06 $17,608 - $21,309	-150 Reduced 0.33%	45,817 $5.79 Million
Q4 2022 Feb 10, 2023	SELL	$120.16 - $142.73 $36,648 - $43,532	-305 Reduced 0.66%	45,967 $5.61 Million
Q3 2022 Nov 14, 2022	SELL	$119.7 - $141.48 $865,431 - $1.02 Million	-7,230 Reduced 13.51%	46,272 $5.63 Million
Q2 2022 Aug 08, 2022	SELL	$113.6 - $139.82 $78,838 - $97,035	-694 Reduced 1.28%	53,502 $6.94 Million
Q1 2022 May 12, 2022	SELL	$131.21 - $167.55 $624,165 - $797,035	-4,757 Reduced 8.07%	54,196 $7.41 Million
Q4 2021 Feb 10, 2022	SELL	$149.18 - $172.5 $28,791 - $33,292	-193 Reduced 0.33%	58,953 $9.94 Million
Q3 2021 Nov 15, 2021	SELL	$129.2 - $150.61 $93,411 - $108,891	-723 Reduced 1.21%	59,146 $8.58 Million
Q2 2021 Aug 06, 2021	SELL	$119.87 - $133.92 $214,447 - $239,582	-1,789 Reduced 2.9%	59,869 $7.86 Million
Q1 2021 May 11, 2021	BUY	$107.03 - $131.53 $20,014 - $24,596	187 Added 0.3%	61,658 $7.73 Million
Q4 2020 Feb 02, 2021	BUY	$98.58 - $115.22 $42,685 - $49,890	433 Added 0.71%	61,471 $7.08 Million
Q3 2020 Nov 12, 2020	SELL	$91.61 - $103.46 $140,346 - $158,500	-1,532 Reduced 2.45%	61,038 $5.96 Million
Q2 2020 Aug 13, 2020	SELL	$80.3 - $102.54 $42,318 - $54,038	-527 Reduced 0.84%	62,570 $5.94 Million
Q1 2020 May 26, 2020	BUY	$81.49 - $113.6 $5.14 Million - $7.17 Million	63,097 New	63,097 $6.23 Million
Q1 2020 May 15, 2020	SELL	$81.49 - $113.6 $5.13 Million - $7.15 Million	-62,957 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$96.34 - $105.25 $94,798 - $103,566	-984 Reduced 1.54%	62,957 $6.4 Million
Q3 2019 Nov 14, 2019	SELL	$83.01 - $105.34 $31,460 - $39,923	-379 Reduced 0.59%	63,941 $6.34 Million
Q2 2019 Aug 12, 2019	BUY	$90.69 - $102.96 $41,717 - $47,361	460 Added 0.72%	64,320 $6.43 Million
Q1 2019 May 13, 2019	BUY	$76.21 - $95.45 $110,733 - $138,688	1,453 Added 2.33%	63,860 $5.93 Million
Q4 2018 Feb 12, 2019	BUY	$73.39 - $110.81 $152,797 - $230,706	2,082 Added 3.45%	62,407 $4.89 Million
Q3 2018 Nov 09, 2018	BUY	$97.22 - $116.69 $1.01 Million - $1.21 Million	10,373 Added 20.77%	60,325 $6.76 Million
Q2 2018 Aug 14, 2018	SELL	$80.7 - $100.4 $140,095 - $174,294	-1,736 Reduced 3.36%	49,952 $4.9 Million
Q1 2018 May 11, 2018	SELL	$70.84 - $82.37 $392,170 - $456,000	-5,536 Reduced 9.67%	51,688 $4.23 Million
Q4 2017 Feb 13, 2018	BUY	$79.39 - $87.71 $9,129 - $10,086	115 Added 0.2%	57,224 $4.61 Million
Q3 2017 Nov 13, 2017	BUY	$73.12 - $81.91 $204,004 - $228,528	2,790 Added 5.14%	57,109 $4.64 Million
Q2 2017 Aug 11, 2017	SELL	N/A	-1,385 Reduced 2.49%	54,319 $4.22 Million
Q2 2017 Aug 10, 2017	BUY	N/A	55,704	55,704 $4.67 Million

Others Institutions Holding BCPC

# of Institutions

348

Shares Held

29.2M

Call Options Held

89.7K

Put Options Held

100

View Full List

About BALCHEM CORP

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.59B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

More about BCPC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account